Combining rapamycin and trametinib seemed to have a cumulative effect in both sexes but mostly in females [1]. These results are probably due to a reduction in both cancer and inflammation.

https://www.lifespan.io/news/rapamycin-trametinib-increase-mouse-lifespan-by-up-to-35/